They demonstrated an elevation in clusterin in frontotemporal dementia (FTD), PSP, and CBD—NDDs with dominant tau or TAR DNA-binding protein (TDP)-43 proteinopathy but minimal α-synuclein pathology—as compared to healthy individuals. This evidence concerns the gene CLU and red-green color blindness.